HLSs with chronic fatigue (N= 143) | HLSs without chronic fatigue (N= 333) | p-value | |
---|---|---|---|
Gender (N (%)) | .87 | ||
Male | 81 (56) | 186 (57) | |
Female | 62 (44) | 147 (43) | |
Age at time of the study | .37 | ||
(years)(mean ± SD) | 47 (11.3) | 46 (11.8) | |
Age at diagnosis | .98 | ||
(years)(mean ± SD) | 30 (10.6) | 30 (10.6) | |
Observational time | .07 | ||
(months)(mean ± SD) | 204 (89.5) | 189 (82.6) | |
Marital status (N (%)) | .47 | ||
Single | 21 (14) | 38 (11.) | |
Married/cohabitant | 105 (73) | 250 (75) | |
Divorced/separated | 3 (2) | 9 (3) | |
Widow/widower | 14 (10) | 35 (11) | |
Educational Level (N (%)) | .11 | ||
≤ 10 years | 29 (20) | 60 (18) | |
≥ 11 years, | 54 (38) | 151 (46) | |
University < 4 years | 21 (15) | 67 (21) | |
University ≥ 4 years | 38 (27) | 49 (15) | |
Stage/substage N (%) | .05 | ||
IA/IIA | 60 (42) | 171 (51) | |
IB/IIB | 30 (21) | 39 (12) | |
IIIA/IVA | 23 (16) | 58 (17) | |
IIIB/IVB | 29 (20) | 65 (20) | |
Primary treatment (N (%)) | .18 | ||
Chemotherapy | 26 (18) | 55 (16) | |
Radiotherapy | 39 (27) | 108 (32) | |
Radiotherapy +Chemotherapy | 76 (53) | 168 (51) | |
Other treatment | 1 (1) | 1 (1) | |
Missing | 1 | 3 | |
Relapse N (%) | 16 (1) | 38 (11) | .81 |
Non-CR | 11 (8) | 23 (7) |